IXC Charting Thread, page-417

Jabra, I can sense your frustration. Honestly, in a coin-flip fully funded phase 3 bio scenario my personal opinion is that I actually want the price to go lower. Allows me to average in and build a position over time at a better price point. Ideally re-rates prior to read out to about 50% of the price it would be if it is successful in phase 3, though it may not. If re-rates then you could potentially de-risk be selling some prior to the coin flip. If it doesn't then you could just hold into the read-out. Neuren being stuck in the doldrums for years during phase 3 allowed me to average in over time, it then didn't re-rate prior to the phase 3 read out, so I just held all my stock, now it is my most successful investment. Something similar could potentially happen here. IMHO, not advice.